Navigation Links
PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies
Date:12/8/2011

BOSTON Prostate cancer screening that combines an adjusted blood test with other factors including the size of the gland, the patient's overall weight and family history, can help up to one-quarter of men avoid biopsies and the risks associated with them, a Beth Israel Deaconess Medical Center-led research team says.

Writing in a study published online by the journal Cancer, the team led by Martin G. Sanda, MD, Director of the Prostate Center at Beth Israel Deaconess Medical Center and Professor of Urology at Harvard Medical School, suggests that instead of using "one-size-fits-all" levels of PSA to determine who should have a biopsy, considering other factors such as prostate size can substantially improve the ability of PSA testing to identify aggressive prostate cancers for which treatment is warranted, while avoiding detection of indolent cancers that are better undiagnosed because they do not require treatment.

A second study led by Sanda, and published online in the journal Urologic Oncology, suggests the presence or absence of genes commonly found in the urine of men, when combined with a PSA test, can also be used to determine whether a biopsy is necessary.

The new suggested approaches come as the United States Preventive Services Task Force expert panel concluded that current PSA-based prostate cancer screening saves few or no lives, but causes harm through treatment or further invasive testing such as biopsies.

That's because prostate cancers can vary in aggressiveness and more men die of other causes aside from that cancer and because the PSA test alone cannot determine how dangerous any particular cancer may be.

"The US Preventative Services Task Force threw the baby out with the bathwater by their blanket recommendation against prostate cancer screening," says Sanda, noting that PSA screening can instead be refined to more selectively identify only aggressive cancer for which treatment is indicated
'/>"/>

Contact: Jerry Berger
jberger@bidmc.harvard.edu
617-667-7308
Beth Israel Deaconess Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Adults in Puerto Rico aware of genetic testing, but use remains low
2. Combined arterial imaging technology reveals both structural and metabolic details
3. Novel combined therapy extends life, diminishes pain in brain cancer patients
4. Ultrasound combined with pre-operative MRI is cost effective in evaluating rotator cuff tears
5. Combined imaging technologies may better identify cancerous breast lesions
6. Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment
7. Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
8. New Laser Technology Combined with Manual Physical Therapy Offer Pain Relief to Chronic Pain Sufferers
9. Singapore Performs Asia's First Combined Heart and Liver Transplant
10. Promega Maxwell 16 IVD System CE Marked to the European Union IVD Directive Delivers Combined Solution for Infectious Disease
11. ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... As reported in a ... series, “Atlanta Plastic” is getting attention for moving outside traditional ethnic stereotypes when ... African-American cast of doctors and patients. Beverly Hills based plastic surgeon Payam Jarrah-Nejad, ...
(Date:8/3/2015)... ... August 03, 2015 , ... BESLER Consulting today ... B2B Awards. , The MarketingProfs Bright Bulb B2B Awards celebrate the best marketing, ... for the launch of their Readmissions Analytics product was selected as one of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent Pharma Solutions, the ... and consumer health products, today welcomed the announcement by OPKO Health that the ... for a new treatment for chronic kidney disease (CKD) and vitamin D insufficiency, ...
(Date:8/3/2015)... ... August 03, 2015 , ... The art of preparing and ... her grandmother’s side at a young age, Nasreen Zereshki was extremely eager to cook ... share her cookbook Recipes from My Persian Kitchen with the world. , Since Americans ...
(Date:8/3/2015)... ... 2015 , ... The U.S. Food and Drug Administration (FDA) recently approved a ... acid, which occurs naturally in the body and helps absorb and breakdown fat cells. ... the body. These are invasive procedures and very expensive for most people. Now with ...
Breaking Medicine News(10 mins):Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3
... Ex-police officer and certified search & rescue manager won contest to ... , LOS ANGELES, June 17 Can ... of the late search and rescue dog and 9-11 hero, Trakr, ... 2009. BioArts International, a Northern California biotech company that is offering ...
... ... ... -- The IMTA and PATA recently signed a Memorandum of Understanding (MOU) to promote healthcare ... development of this high value sector and drive more integration between the travel and healthcare ...
... ... practice to a brand new state of the art location at 5044 Tennyson in Plano. ... Laser Surgery. , ... 2009 -- Dr. Bryan Selkin, the Chief Dermatologist of the Dermatology Center of Plano will be ...
... Two Cold Remedy Nasal Products Citing Commitment to Consumer Safety ... Matrixx Initiatives, Inc. (Nasdaq: MTXX ) has confirmed ... Food and Drug Administration about two of its 19 existing ... Cold Remedy Swabs. The warning letter cited consumer reports that ...
... June 16 Mammography has long been the standard for ... tissue can make tumors difficult to find. According to ... tissue are five times more likely to develop breast cancer. ... SI ) at: http://inr.mediaseed.tv/oneClip_C/?feed=KmAdskkAWyriUTQcX9fLjuG_zA0wEhsO ...
... PHILADELPHIA, June 16 United States Attorney Michael L. ... today announced the return of an indictment(1.) against Norian ... executives, Michael D. Huggins (Huggins), Thomas B. Higgins (Higgins), ... charging them for their involvement in conducting clinical trials ...
Cached Medicine News:Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 2Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 3Health News:The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel 2Health News:The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel 3Health News:New State of the Art Dermatology Center in Plano TX 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 3Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 2Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 3Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 4Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 5Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 6Health News:International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials 7
(Date:8/3/2015)... CAMBRIDGE, Mass. , Aug. 3, 2015 ... the company will host its Second Quarter 2015 Investor ... August 10.    The call will cover ... summary of second quarter 2015 financials. A press release ... will be issued the afternoon of Monday, August 10. ...
(Date:8/3/2015)... SAN FRANCISCO, Calif. , Aug. 3, 2015 ... for the treatment of cancer, today announced the ... Debanjan Ray , who previously ... alliance management, has been promoted to senior vice ... joining CytomX, Mr. Ray held positions as the ...
(Date:8/3/2015)... 3, 2015  Celsion Corporation (NASDAQ: CLSN ... a conference call to discuss its second quarter ... its development programs for ThermoDox®, its proprietary heat-activated ... technology platforms, TheraPlas™ and TheraSilence™, in immunotherapy and ... August 10, 2015. To participate in the call, ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2
... New England Journal of Medicine employs Quest Diagnostics, blood-based ... of blood specimens may detect abnormal white blood cells ... leukemia (CLL) develops, according to research published in the ... Journal of Medicine . The finding may lead to ...
... Pharmacyclics (Nasdaq: PCYC ) announced today ... investment by the principals of Pacific Biopharma Group, Ltd. ... Province, People,s Republic of China. The transaction was structured ... Pharmacyclics at $0.93/share. Robert Duggan, CEO of Pharmacyclics ...
Cached Medicine Technology:Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 2Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 4Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd. 2Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd. 3
... has greatly enhanced the stabilization ... Biomet Low Profile Tibial Nail ... treatment of unstable fractures, tibial ... pathologic or impending fractures but ...
Arthroscopic instrument system for instability and SLAP fixation....
Arthroscopic instrument system for instability and SLAP fixation....
Suture Cutter, Open Ended, Left Notch...
Medicine Products: